Thanks to our speakers, panelists, partner organizations and the attendees for making the 2008 Ohio Biz/Bio Event a success!
Dr. Silverstein received his undergraduate degree in Biology from Brown University and his Medical degree from Emory University. After completing clinical training in Internal Medicine, Hematology and Medical Oncology at New York Hospital-Cornell Medical Center in Manhattan he joined the faculty at Cornell where he spent nearly 20 years, rising through the ranks to Professor of Medicine and Chair of the Division of Hematology/Oncology. Dr. Silverstein joined the Cleveland Clinic in April, 2004 as Chair of the Department of Cell Biology and Vice Chair of the Lerner Research Institute. Under his leadership the Department has grown to 21 independent principal investigators and more than 100 support staff engaged in cutting edge biomedical research and education. His own research focuses on the molecular and cellular basis of human vascular diseases, including thrombosis, atherosclerosis, and cancer-associated angiogenesis. He is director of the NIH-funded Cleveland Clinic Specialized Center of Clinically Oriented Research (SCCOR) in Thrombosis and an NIH-funded program project on vascular pathobiology. Dr. Silverstein is very active in medical and PhD education, serving as part of the leadership team of the Cleveland Clinic Lerner College of Medicine and as a PhD trainer for Case Graduate School and Cleveland State University. On a national level, Dr. Silverstein has chaired multiple NIH, American Heart Association, Howard Hughes Medical Institute and Veteran’s Administration grant review panels, as well as national conferences on research into blood and vascular diseases. He has published over 100 articles in his field and serves on the editorial board of several prestigious scientific journals. He is an elected member of the American Society of Clinical Investigation and the Association of American Physicians and has served as President of the American Society for Clinical Research. He is currently Chair of the Government Affairs Committee for the American Society of Hematology.
